The cornerstones of success to redefine regional pharma
Develop UAE-based biotech and life sciences parks
Increasing the UAE’s manufacturing capabilities
Drive collaboration among stakeholders
Bilateral relationships need to continue to be leveraged to foster investment in clinical research that addresses local and regional healthcare needs. By establishing cooperation between the public and private sectors and academia, public health programs and research can be more robust.
Establish a robust life sciences R&D ecosystem
Capture the use of cutting-edge technologies
Grow a highly skilled talent pool
Grow a highly skilled talent pool
Technological advances offer the potential for the UAE to reduce its reliance on importing medical equipment and products. For example, UAE universities are exploring the potential for 3D printing. Two Mechanical Engineering students from Khalifa University presented a lower limb prosthetic manufactured using 3D printing at Innovator 2020 in Abu Dhabi, which costs less than $1,000 to print and can be produced in 48 hours.
The complexity of pharmaceuticals and life sciences elevates the importance of having a deep talent pool. DoH recently announced a collaboration with Pfizer to train up to 150 clinical researchers within two years. In addition, the UAE has launched the “Projects of the 50” initiative that aims to bring 10,000 UAE Nationals into the medical field in the next five years via scholarships in various healthcare disciplines.
